Paul Matthias Diderichsen Selected Research

N- ((4'- hydroxybiphenyl- 3- yl)methyl)- 2- (3- (2- ((- 2- hydroxy- 2- (4- hydroxy- 3- ((methylsulfonyl)amino)phenyl)ethyl)amino)- 2- methylpropyl)phenyl)acetamide

11/2013	Predicted heart rate effect of inhaled PF-00610355, a long acting β-adrenoceptor agonist, in volunteers and patients with chronic obstructive pulmonary disease.
6/2013	Characterizing systemic exposure of inhaled drugs: application to the long-acting β2-agonist PF-00610355.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Matthias Diderichsen Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 01/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2013 - 06/2013
1	Body Weight (Weight, Body) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Rheumatoid Arthritis 08/2015
1	Crohn Disease (Crohn's Disease) 08/2015
1	Asthma (Bronchial Asthma) 06/2013

Drug/Important Bio-Agent (IBA)

2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2022
2	simurosertibIBA 01/2022 - 01/2022
2	N- ((4'- hydroxybiphenyl- 3- yl)methyl)- 2- (3- (2- ((- 2- hydroxy- 2- (4- hydroxy- 3- ((methylsulfonyl)amino)phenyl)ethyl)amino)- 2- methylpropyl)phenyl)acetamideIBA 11/2013 - 06/2013
1	CreatinineIBA 01/2022
1	lysophosphatidic acidIBA 01/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2019
1	GLPG1690IBA 01/2019
1	Janus Kinase 1IBA 08/2015
1	GLPG0634IBA 08/2015
1	Pharmaceutical PreparationsIBA 11/2013
1	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2013

Therapy/Procedure

1	Oral Administration 01/2022